First Causal, Anti-inflammatory Treatment of Diabetic Nephropathy
SANEMUS supports a biotech start-up in fundraising. The start-up focusses on diabetic complications and is currently developing the first causal, anti-infalmmatory treatment of diabetic nephropathy.
If you are interested in an investment, please contact us.